The Third Australian Atlas of Healthcare Variation, released 11 December 2018, investigates healthcare use in four clinical areas: paediatric and neonatal health, cardiac tests, thyroid investigations and treatments, and gastrointestinal investigations and treatments.
It also examines national patterns in medicines use over time for four common groups of medicines: antipsychotics, opioids, antimicrobials and medications for attention deficit hyperactivity disorder (ADHD). A more detailed exploration of these data will be published in 2019.
To make it easier to access the level of detail you require we offer a number of ways to view the full Atlas and its findings:
The 2018 Atlas contains some concerning findings and important recommendations to increase the appropriateness of care delivered to a number of people in the community.
It is important that all health professionals are aware of these findings and recommendations so clinicians and consumers can make fully informed decisions.
Please assist us in promoting these findings to your health organisation or via your social media channels using the communication materials that we have developed.
I would like to thank the Australian Institute of Health and Welfare, and the Australian, state and territory health departments for partnering with the Commission to produce this Atlas, and to acknowledge the many clinicians, consumers, clinical colleges and societies, and policymakers from all Australian governments who have collaborated with the Commission on this work.
Their insights have been invaluable in helping us to understand the patterns in the Atlas data, and have provided the foundations for important and achievable recommendations.
Professor Villis Marshall AC
Australian Commission on Safety and Quality in Health Care
11 December 2018